Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Emma Bardsley won two prizes: BHF CRE Annual Symposium 2016: 19/9/2016 - Runner Up Poster Prize and OXION Annual Symposium 2016: 30/9/2016 - Winner of the Journal of General Physiology Poster Prize

Emma Bardsley

Congratulations to Emma Bardsley, a postgraduate student in the Paterson lab on these two recent prizes.

The awards were presented to Emma for her research investigating whether beta adrenergic blockers, the current gold standard treatment for cardiovascular disease, may also act via the peripheral nervous system.

Emma's data suggests that beta 1 and beta 2 adrenoceptors are present in both human and rat sympathetic stellate ganglia. Moreover, isoprenaline-dependent stimulation of cAMP-PKA signalling and mobilisation of intracellular calcium is enhanced in neurons obtained from the pro-hypertensive SHR rat. 

Similar stories

Winners of the DPAG Student Poster Day 2021 announced

"A Year of Progress" was held in the Sherrington Library and Sherrington PCR Café on Thursday 18 November 2021.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.

Wade-Martins Group achieves Bronze award for sustainable practices

The Wade-Martins Group has achieved a Laboratory Efficiency Assessment Framework (LEAF) Bronze award in recognition of its sustainable practices.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.

Drug could help diabetic hearts recover after a heart attack

New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.